Treatment With Mepolizumab on Patients With Severe Refractory Eosinophilic Asthma

Clinical trial NCT05063981 · COMPLETED

Trial details

NCT number: NCT05063981
Sponsor: Istituti Clinici Scientifici Maugeri SpA
Status: COMPLETED
Study type: OBSERVATIONAL

Severe Eosinophilic Asthma

Start date: 2021-11-25
Primary completion: 2023-09-29
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.